PDCD1 and neoplasm: Thus, melanoma patients with high levels of precursor exhausted TILs respond better to anti-PD-1 than patients with lower levels, or with high levels of terminally exhausted TILs.12 Approaches to expand the population of tumor-specific precursor exhausted T cells could be one way to improve the response to checkpoint blockade.